Janux Therapeutics
JANXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$985.525 M
$16.12 -11.33%
Close of 6 Nov 2026
As of 6 Nov 2026, Janux Therapeutics (JANX) has a market capitalization of $985.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$113.6M
Loss-making
Shares outstanding
61,183,417
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #142COMPASS PathwaysCMPS$1.11B
- #143Seaport TherapeuticsSPTX$1.09B
- #144Janux TherapeuticsJANX$985.5M
- #145HarrowHROW$975.1M
- #146MoonLake ImmunotherapeuticsMLTX$919.6M
What if Janux Therapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Janux Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.